| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.063 | 0.2 |